MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics P/S Ratio 2011-2026 | AXDX
Annual P/S Ratio Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.5 | 96.4 | 38 | 97.7 | 176 | 377 | 4.11 K | 4.53 K | 7.69 K | 10.8 K | 153 | 30.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 K | 13.5 | 2.34 K |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
5.13 | $ 6.05 | 6.14 % | $ 178 M |  USA |
 |
Brainsway Ltd.
BWAY
|
8.09 | $ 22.03 | 3.19 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 22.9 | 19.89 % | $ 246 M |  China |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
2.13 | $ 12.11 | -10.18 % | $ 344 M | Israel |
 |
DexCom
DXCM
|
13.5 | $ 70.15 | 0.37 % | $ 27.1 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.62 | -0.03 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 27.97 | 7.62 % | $ 846 M | USA |
 |
BioNano Genomics
BNGO
|
0.115 | $ 1.6 | -0.62 % | $ 2.03 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
2.14 | $ 40.8 | 1.83 % | $ 1.13 B | USA |
 |
Danaher Corporation
DHR
|
6.37 | $ 234.89 | -0.73 % | $ 172 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
1.86 | $ 18.99 | 0.96 % | $ 1.02 B | USA |
 |
Myriad Genetics
MYGN
|
1.16 | $ 6.7 | 2.68 % | $ 607 M | USA |
 |
Anixa Biosciences
ANIX
|
0.337 | $ 3.26 | 2.4 % | $ 104 K | USA |
 |
NeoGenomics
NEO
|
2.31 | $ 12.69 | -0.78 % | $ 1.61 B | USA |
 |
IQVIA Holdings
IQV
|
2.31 | $ 244.09 | 1.5 % | $ 44.3 B | USA |
 |
Natera
NTRA
|
6.47 | $ 254.88 | 2.47 % | $ 25.1 B | USA |
 |
OPKO Health
OPK
|
6.61 | $ 1.36 | 3.03 % | $ 944 M | USA |
 |
Guardant Health
GH
|
7.91 | $ 110.12 | -1.97 % | $ 13.5 B | USA |
 |
Pacific Biosciences of California
PACB
|
7.05 | $ 2.12 | 1.92 % | $ 538 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 29.05 | 1.22 % | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Illumina
ILMN
|
3.75 | $ 151.07 | 2.65 % | $ 24 B | USA |
 |
Charles River Laboratories International
CRL
|
2.11 | $ 216.28 | - | $ 11.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.51 | -1.96 % | $ 2.42 M | USA |
 |
Neogen Corporation
NEOG
|
1.14 | $ 7.28 | -1.75 % | $ 1.58 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 178.22 | -1.22 % | $ 19.8 B | USA |
|
Biodesix
BDSX
|
1.29 | $ 5.86 | -2.82 % | $ 760 M | USA |
 |
Trinity Biotech plc
TRIB
|
1.47 | $ 0.76 | -1.18 % | $ 61.9 M |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 253.83 | -2.49 % | $ 21.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 202.64 | 0.58 % | $ 16.7 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
9.66 | $ 710.27 | 0.49 % | $ 58.6 B | USA |
 |
Lantheus Holdings
LNTH
|
4.21 | $ 69.22 | -0.66 % | $ 4.79 B | USA |
 |
Agilent Technologies
A
|
6.64 | $ 147.47 | -0.1 % | $ 44.8 B | USA |